Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Explore effective ways to earn money with side jobs now. Choose options that fit your lifestyle and start today.
22,363 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
A growing wave of AI-mediated workplace chats is changing how employees and managers communicate, with potential ripp...
Alphabet and Meta delivered divergent Q4 results, underscoring different paths to durable profits. Cloud, AI, and cap...
MP Materials faced a notable price drop in June, but the reasons run deeper than a single policy move. This article b...
IVV and SPY both track the S&P 500, but they aren’t identical. This guide breaks down cost, liquidity, tax considerat...
A $1 million single-life annuity paying $6,100 a month may look like strong retirement income, but it ends at death. ...
XRP is testing a breakout near $1.50 as institutional inflows and rising derivatives support a bullish setup. But a m...
A retiring CFO faces a pivotal decision: take a lump-sum payout from a long‑standing nonqualified deferred compensati...
Solana surged 13% last week, its strongest performance of 2026, driven by ETF demand and higher futures activity. Tra...
AI relies on chips to power today’s breakthroughs. This article uncovers a less-prominent semiconductor ETF idea, why...
As growth ETFs pivot in 2026, the case for a tighter mega-cap tilt strengthens. This analysis weighs performance, con...
A New York tech startup is financing workers’ housing near its expensive offices, spending roughly $1.7 million annua...